Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination
Clinical trial NCT01651481 · COMPLETED
Trial details
- NCT number
- NCT01651481
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2012-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.